Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis

被引：7

作者：

Bozdogan, B ^{[1
]}

Appelbaum, PC

Ednie, L

Grivea, IN

Syrogiannopoulos, GA

机构：

[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA 17033 USA

[2] Univ Patras, Sch Med, Dept Pediat, GR-26110 Patras, Greece

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2003年 / 9卷 / 09期

关键词：

Streptococcus pyogenes; macrolide resistance; ribosomal mutation;

D O I：

10.1046/j.1469-0691.2003.00670.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Streptococcus pyogenes isolates with the same pulsed-field patterns were recovered from the throat cultures of a child with tonsillopharyngitis before and after treatment with miocamycin, a 16-membered macrolide. The initial isolate was macrolide-susceptible, but the isolates after the treatment were resistant to 14 and 15-membered macrolides and had two amino acid (65WR66) deletions in ribosomal protein L4.

引用

页码：966 / 969

页数：4

共 20 条

[11] Emergence of macrolide resistance during treatment of pneumococcal pneumonia [J].

Musher, DM ;

Dowell, ME ;

Shortridge, VD ;

Flamm, RK ;

Jorgensen, JH ;

Le Magueres, P ;

Krause, KL .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :630-631

[12] Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 Central and Eastern European countries [J].

Nagai, K ;

Appelbaum, PC ;

Davies, TA ;

Kelly, LM ;

Hoellman, DB ;

Tambic Andrasevic, A ;

Drukalska, L ;

Hryniewicz, W ;

Jacobs, MR ;

Kolman, J ;

Miciuleviciene, J ;

Pana, M ;

Setchanova, L ;

Thege, MK ;

Hupkova, H ;

Trupl, J ;

Urbaskova, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :546-549

[13] Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 pneumococci from 10 Central and Eastern European countries [J].

Nagai, K ;

Appelbaum, PC ;

Davies, TA ;

Kelly, LM ;

Hoellman, DB ;

Tambic Andrasevic, A ;

Drukalska, L ;

Hryniewicz, W ;

Jacobs, MR ;

Kolman, J ;

Miciuleviciene, J ;

Pana, M ;

Setchanova, L ;

Thege, MK ;

Hupkova, H ;

Trupl, J ;

Urbaskova, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) :371-377

[14]

National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS

[15] Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships:: Results of a 1-year (1998-1999) multicenter surveillance study in Spain [J].

Pérez-Trallero, E ;

Fernández-Mazarrasa, C ;

García-Rey, C ;

Bouza, E ;

Aguilar, L ;

García-de-Lomas, J ;

Baquero, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3334-3340

[16]

Seppälä H, 1998, ANTIMICROB AGENTS CH, V42, P257

[17] Detection of erythromycin-resistant determinants by PCR [J].

Sutcliffe, J ;

Grebe, T ;

TaitKamradt, A ;

Wondrack, L .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (11) :2562-2566

[18] High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children [J].

Syrogiannopoulos, GA ;

Grivea, IN ;

Fitoussi, F ;

Doit, C ;

Katopodis, GD ;

Bingen, E ;

Beratis, NG .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (09) :863-868

[19] Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America [J].

Tait-Kamradt, A ;

Davies, T ;

Appelbaum, PC ;

Depardieu, F ;

Courvalin, P ;

Petitpas, J ;

Wondrack, L ;

Walker, A ;

Jacobs, MR ;

Sutcliffe, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (12) :3395-3401

[20] Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California [J].

York, MK ;

Gibbs, L ;

Perdreau-Remington, F ;

Brooks, GF .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1727-1731

← 1 2 →